Alzheimer's Disease Trial, Recruiting (NCT07042087)

Alzheimer's Disease Trial, Recruiting NCT07042087 Sponsor: St. Anne's University Hospital Brno, Czech Republic Condition: Alzheimer's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07042087 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Alzheimers Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 60 and 80 years old
You have been diagnosed with either Subjective Cognitive Impairment (feeling like your memory or thinking has declined) or Mild Cognitive Impairment (a mild but measurable change in memory or thinking)
You scored between 24 and 30 on a standard memory and thinking test called the MMSE (a common short assessment used by doctors)
A blood test has shown a positive result for a specific brain-related marker called pTau217, which is linked to cognitive changes (confirm with trial site)
If you are currently taking a type of medication for memory or thinking, you have been on a stable, unchanged dose of it
You are able to commit to and take part in a 9-month programme

Who may not be able to join:

You have had a stroke or heart attack within the past year
You have a serious uncontrolled internal health condition, such as severe heart failure, kidney failure, unstable diabetes, or are taking a certain type of diabetes/weight medication called a GLP1 agonist (confirm with trial site)
You are receiving long-term treatment for a psychiatric condition, unless it is well-controlled depression
You have a neurological condition that affects your movement or thinking, such as Parkinson's disease, severe tremor, or epilepsy
You have a serious problem with your senses (such as vision or hearing) or physical movement that would prevent you from taking part in the study activities
You have had cancer that was being actively treated within the past 5 years
There are concerns that attending regularly may be difficult for you, for example due to transport, time, or other practical issues
You are currently taking part in another clinical trial
Your memory or thinking medication has been recently changed or is not yet at a steady dose
You have a dependence on alcohol or other substances

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07042087

Sponsor: St. Anne's University Hospital Brno, Czech Republic

Phase: Not Applicable

Status: Recruiting

Condition: Alzheimer's Disease

More information: https://clinicaltrials.gov/study/NCT07042087

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 60 and 80 years old
You have been diagnosed with either Subjective Cognitive Impairment (feeling like your memory or thinking has declined) or Mild Cognitive Impairment (a mild but measurable change in memory or thinking)
You scored between 24 and 30 on a standard memory and thinking test called the MMSE (a common short assessment used by doctors)
A blood test has shown a positive result for a specific brain-related marker called pTau217, which is linked to cognitive changes (confirm with trial site)
If you are currently taking a type of medication for memory or thinking, you have been on a stable, unchanged dose of it
You are able to commit to and take part in a 9-month programme

Who may not be able to join:

You have had a stroke or heart attack within the past year
You have a serious uncontrolled internal health condition, such as severe heart failure, kidney failure, unstable diabetes, or are taking a certain type of diabetes/weight medication called a GLP1 agonist (confirm with trial site)
You are receiving long-term treatment for a psychiatric condition, unless it is well-controlled depression
You have a neurological condition that affects your movement or thinking, such as Parkinson's disease, severe tremor, or epilepsy
You have a serious problem with your senses (such as vision or hearing) or physical movement that would prevent you from taking part in the study activities
You have had cancer that was being actively treated within the past 5 years
There are concerns that attending regularly may be difficult for you, for example due to transport, time, or other practical issues
You are currently taking part in another clinical trial
Your memory or thinking medication has been recently changed or is not yet at a steady dose
You have a dependence on alcohol or other substances

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

St. Anne's University Hospital Brno, Czech Republic

Registry

ClinicalTrials.gov

Start date

1 November 2024

Est. completion

1 December 2026

Where this trial is recruiting

🇨🇿 Czechia

Primary endpoints

Composite Score of Cognitive Function; Plasma Biomarkers of Neurodegeneration

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov